<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Cystic medial degeneration (CMD) is a histological abnormality that is common in the <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic diseases</z:e> associated with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Although little known about the mechanism underlying CMD, several recent reports have demonstrated that vascular smooth muscle cell (VSMC) <z:mpath ids='MPATH_3'>apoptosis</z:mpath> could play a substantial role in CMD </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> (<z:chebi fb="0" ids="48432">Ang II</z:chebi>) has been reported to play an important role in the regulation of VSMC growth and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via the <z:chebi fb="0" ids="48432">Ang II</z:chebi> type 1 receptor (AT1R) and type 2 receptor (AT2R) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: To elucidate the role of <z:chebi fb="0" ids="48432">Ang II</z:chebi> signaling via the <z:chebi fb="0" ids="48432">Ang II</z:chebi> receptors in CMD, we investigated AT1R and AT2R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and tissue concentration of <z:chebi fb="0" ids="48432">Ang II</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> aortas (n=10) and control aortas (n=12) </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, we examined the effects of an <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi>, an AT1R blocker, and an AT2R blocker on serum deprivation-induced VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by organ culture system </plain></SENT>
<SENT sid="5" pm="."><plain>AT1R expression was significantly decreased (P&lt;0.01) and AT2R expression was significantly increased (P&lt;0.001) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> aortas compared with control aortas, and tissue <z:chebi fb="0" ids="48432">Ang II</z:chebi> concentration was significantly higher in CMD than in the control condition (P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Both the <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi> and AT2R blocker significantly inhibited serum deprivation-induced VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P&lt;0.05), although the AT1R blocker did not inhibit <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in cultured aortic media from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Accelerated ACE-dependent <z:chebi fb="0" ids="48432">Ang II</z:chebi> formation and signaling via upregulated AT2R play a pivotal role in VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in CMD, and the <z:chebi fb="2" ids="35457">ACE inhibitor</z:chebi> could have clinical value in the prevention and treatment of CMD </plain></SENT>
</text></document>